Oncosil Medical Ltd - Asset Resilience Ratio

Latest as of June 2025: 0.00%

Oncosil Medical Ltd (OSL) has an Asset Resilience Ratio of 0.00% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Oncosil Medical Ltd (OSL) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

AU$0.00
≈ $0.00 USD Cash + Short-term Investments

Total Assets

AU$7.15 Million
≈ $5.06 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Oncosil Medical Ltd's Asset Resilience Ratio has changed over time. See Oncosil Medical Ltd shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Oncosil Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Oncosil Medical Ltd (OSL) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Oncosil Medical Ltd maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Oncosil Medical Ltd Industry Peers by Asset Resilience Ratio

Compare Oncosil Medical Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Vitrolife AB
ST:VITR
Medical Devices 7.27%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Tellgen Corp
SHE:300642
Medical Devices 8.60%
Lumos Diagnostics Holdings Ltd
AU:LDX
Medical Devices 9.40%
T&R Biofab Co. Ltd
KQ:246710
Medical Devices 0.12%
Ok Biotech Co Ltd
TW:4155
Medical Devices 0.32%
Promimic AB
ST:PRO
Medical Devices 8.62%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

Annual Asset Resilience Ratio for Oncosil Medical Ltd (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Oncosil Medical Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 0.00% AU$0.00
≈ $0.00
AU$7.15 Million
≈ $5.06 Million
--
2024-06-30 0.00% AU$0.00
≈ $0.00
AU$6.72 Million
≈ $4.75 Million
--
2023-06-30 1.02% AU$116.57K
≈ $82.48K
AU$11.47 Million
≈ $8.12 Million
+0.33pp
2022-06-30 0.68% AU$89.27K
≈ $63.16K
AU$13.07 Million
≈ $9.25 Million
+0.04pp
2021-06-30 0.64% AU$90.53K
≈ $64.06K
AU$14.15 Million
≈ $10.01 Million
+0.35pp
2020-06-30 0.29% AU$69.21K
≈ $48.97K
AU$24.06 Million
≈ $17.02 Million
-66.20pp
2019-06-30 66.49% AU$7.76 Million
≈ $5.49 Million
AU$11.67 Million
≈ $8.26 Million
-9.98pp
2018-06-30 76.48% AU$15.21 Million
≈ $10.76 Million
AU$19.88 Million
≈ $14.07 Million
+8.70pp
2017-06-30 67.77% AU$8.00 Million
≈ $5.66 Million
AU$11.80 Million
≈ $8.35 Million
+47.27pp
2016-06-30 20.50% AU$3.26 Million
≈ $2.31 Million
AU$15.90 Million
≈ $11.25 Million
-28.07pp
2015-06-30 48.57% AU$3.60 Million
≈ $2.55 Million
AU$7.41 Million
≈ $5.24 Million
+3.43pp
2014-06-30 45.14% AU$4.35 Million
≈ $3.08 Million
AU$9.64 Million
≈ $6.82 Million
+44.22pp
2013-06-30 0.92% AU$57.35K
≈ $40.58K
AU$6.24 Million
≈ $4.42 Million
-2.24pp
2012-06-30 3.16% AU$79.75K
≈ $56.43K
AU$2.52 Million
≈ $1.79 Million
-1.50pp
2011-06-30 4.66% AU$141.18K
≈ $99.89K
AU$3.03 Million
≈ $2.14 Million
--
pp = percentage points

About Oncosil Medical Ltd

AU:OSL Australia Medical Devices
Market Cap
$8.35 Million
AU$11.81 Million AUD
Market Cap Rank
#27293 Global
#1390 in Australia
Share Price
AU$0.50
Change (1 day)
-2.91%
52-Week Range
AU$0.00 - AU$1.99
All Time High
AU$1.99
About

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company's lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorp… Read more